Company profile
AeproMED company profile
AeproMED's advanced inhalation therapy platform offers quick therapeutic onset while minimizing systemic side effects. Leveraging professional aerosol science, it ensures precise drug-aerosol delivery directly to the lungs. This versatile technology supports animal pre-clinical trials, supportive therapies, and lung disease treatment. Designed with a user-centric approach, it integrates seamlessly with respiratory medicine for chronic disease management. Additionally, it provides cutting-edge technology for developing new compounds to treat cancer or for supportive therapies in sub-health conditions. AeproMED's platform is a significant advancement in the medical and healthcare fields.
Business identity
- Website
- https://www.aepromed.com/
- Contact email
- [email protected]
- Phone number
- +886-3-6676537
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 00011-00050 employees
- Founded
- 2022-01-17
Headquarters
- Headquarters
- Hsinchu, Taiwan, Taiwan
- Postal code
- 302041
- Country code
- TW
- Continent
- Asia